Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 10 min ago
PreprintCC BY-NC-NDbioRxiv

Aggregate Deep Visual Proteomics reveals selective organization of α-synuclein inclusions

10 more authors
  1. 1Max Planck Institute of Biochemistry

Abstract

-Synuclein inclusions, the lesions typical of Parkinson's disease, have been interpreted as protective deposits, toxic species or failed degradation products, each predicting a different composition and correlating that enrichment with neuron dysfunction and eventual degeneration. Distinguishing them requires measuring what an inclusion concentrates relative to the cell that built it. Here we developed Aggregate Deep Visual Proteomics, which uses ultrasensitive mass spectrometry to profile laser-microdissected inclusions against the remainder of the same cell or a matched host. In HEK293 cells, iPSC-derived dopaminergic neurons and post-mortem patient brain, each inclusion concentrated a selective subset of its cell's proteome, independent of abundance and dominated by membrane, in neurons largely presynaptic. Inclusions took up whole assemblies, with subunits moving together in 421 of 438 complexes, and the V-ATPase alone was enriched in all three systems. Degradation cargo stayed with the receptors that route it, consistent with sequestration and failed degradation acting together. Neuritic and somatic inclusions differed, the former rich in UBQLN2 and the latter in intermediate filaments. In the cell line, phosphorylated -synuclein was tenfold higher in the inclusion than in the rest of the cell, with about one third of the rise already present before an inclusion was visible. Measured against its host, the composition of an inclusion becomes a readout of how it formed and a source of candidate markers and therapeutic targets.

Related

  1. Membranes Decouple α‑Synuclein Surface Assembly and Kinetic Restriction from Persistent Amyloid-like Intermolecular Organization.
    Jinyu Chen, Xiakun Chu
    JACS AuPeer-reviewedCC BYFull textNeurologyEurope PMCDOAJPMC
  2. Direct-to-biology approach for the selective identification of ligands for alpha-synuclein aggregates
    Gaëtan Ossard, Clémentine Pescheteau, Timothée D’Anfray +4
    ChemRxivPreprintCC BYFull textNeurologyChemRxiv
  3. Visualizing α‐synuclein pathology in live brain: A new platform for Parkinson's disease research
    Minhui Yu, Peng Cao
    Clinical and Translational MedicinePeer-reviewedCC BYFull textNeurologyDOAJ
  4. The Sulfate-Reducing Bacteria Hypothesis in Parkinson’s Disease: From Desulfovibrio-Derived Hydrogen Sulfide to Alpha-Synuclein Aggregation
    Michał Koterba, Aleksandra Skiba, Anna Kler +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Comparative evaluation of mineral trioxide aggregate, diode and erbium, chromium-doped yttrium, scandium, gallium, and garnet laser-assisted mineral trioxide aggregate pulpotomy in primary molars – A randomized controlled trial
    Vishal Vishal, Gyanendra Kumar, Mridula Goswami +2
    Journal of Indian Society of Pedodontics and Preventive DentistryPeer-reviewedCC BY-NC-SAFull textGeneral medicineDOAJ
BibTeX
@misc{oeller2026aggregate,
  title = {{Aggregate Deep Visual Proteomics reveals selective organization of α-synuclein inclusions}},
  author = {M. Oeller and S. Vasconez Grunauer and C. S. Sitron and A.-L. Mahul Mellier and L. Diedrich and A. Schuele and V. Ruf and D. Oliinyk and F. Kuttler and U. Dransfeld and J. Prassler and S. Ben-Moshe and E. Rodriguez and T. Heymann and E. Ugur and K. Madden and Y. Sun and C. Ulrich and Y. Jasiqi and H. A. Lashuel and F. U. Hartl and M. Mann},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.763157},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763157v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Aggregate Deep Visual Proteomics reveals selective organization of α-synuclein inclusions
AU  - M. Oeller
AU  - S. Vasconez Grunauer
AU  - C. S. Sitron
AU  - A.-L. Mahul Mellier
AU  - L. Diedrich
AU  - A. Schuele
AU  - V. Ruf
AU  - D. Oliinyk
AU  - F. Kuttler
AU  - U. Dransfeld
AU  - J. Prassler
AU  - S. Ben-Moshe
AU  - E. Rodriguez
AU  - T. Heymann
AU  - E. Ugur
AU  - K. Madden
AU  - Y. Sun
AU  - C. Ulrich
AU  - Y. Jasiqi
AU  - H. A. Lashuel
AU  - F. U. Hartl
AU  - M. Mann
PY  - 2026
DA  - 2026/10/30
PB  - bioRxiv
DO  - 10.64898/2026.10.30.763157
UR  - https://www.biorxiv.org/content/10.64898/2026.10.30.763157v1
AB  - -Synuclein inclusions, the lesions typical of Parkinson's disease, have been interpreted as protective deposits, toxic species or failed degradation products, each predicting a different composition and correlating that enrichment with neuron dysfunction and eventual degeneration. Distinguishing them requires measuring what an inclusion concentrates relative to the cell that built it. Here we developed Aggregate Deep Visual Proteomics, which uses ultrasensitive mass spectrometry to profile laser-microdissected inclusions against the remainder of the same cell or a matched host. In HEK293 cells, iPSC-derived dopaminergic neurons and post-mortem patient brain, each inclusion concentrated a selective subset of its cell's proteome, independent of abundance and dominated by membrane, in neurons largely presynaptic. Inclusions took up whole assemblies, with subunits moving together in 421 of 438 complexes, and the V-ATPase alone was enriched in all three systems. Degradation cargo stayed with the receptors that route it, consistent with sequestration and failed degradation acting together. Neuritic and somatic inclusions differed, the former rich in UBQLN2 and the latter in intermediate filaments. In the cell line, phosphorylated -synuclein was tenfold higher in the inclusion than in the rest of the cell, with about one third of the rise already present before an inclusion was visible. Measured against its host, the composition of an inclusion becomes a readout of how it formed and a source of candidate markers and therapeutic targets.
ER  -